Skip to main content
ArticleOPEN ACCESS

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome

Cochrane Database of Systematic Reviews
DOI: 10.1002/14651858.CD012169
57Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the benefits and harms of antiplatelet and anticoagulant agents for the secondary prevention of recurrent thrombosis, particularly ischemic stroke, in people with antiphospholipid syndrome.

Cite

CITATION STYLE

APA

Bala, M. M., Celinska-Lowenhoff, M., Padjas, A., Szot, W., & Undas, A. (2016, April 27). Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD012169

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free